Corton Capital Inc. Pacira Bio Sciences, Inc. Transaction History
Corton Capital Inc.
- $29.1 Million
- Q1 2025
A detailed history of Corton Capital Inc. transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Corton Capital Inc. holds 12,600 shares of PCRX stock, worth $284,130. This represents 1.07% of its overall portfolio holdings.
Number of Shares
12,600
Previous 21,575
41.6%
Holding current value
$284,130
Previous $406,000
22.91%
% of portfolio
1.07%
Previous 0.24%
Shares
3 transactions
Others Institutions Holding PCRX
# of Institutions
256Shares Held
50.9MCall Options Held
157KPut Options Held
139K-
Black Rock Inc. New York, NY8.01MShares$181 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.24MShares$118 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.26MShares$51.1 Million0.06% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.24MShares$50.5 Million0.09% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.05MShares$46.2 Million0.01% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.03B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...